Superoxide dismutase activity in small mesenteric arteries is downregulated by angiotensin II but not by hypertension

Kyu Tae Kang, Jennifer C Sullivan, Jennifer S. Pollock

Research output: Contribution to journalArticle

Abstract

Many studies reported reduced antioxidant capacity in the vasculature under hypertensive conditions. However, little is known about the effects of antihypertensive treatments on the regulation of vascular antioxidant enzymes. Thus, we hypothesized that antihypertensive treatments prevent the reduction of antioxidant enzyme activity and expression in the small vessels of angiotensin II-induced hypertensive rats (ANG). We observed the small mesenteric arteries and small renal vessels of normotensive rats (NORM), ANG, and ANG treated with a triple antihypertensive therapy of reserpine, hydrochlorothiazide, and hydralazine (ANG + TTx). Systolic blood pressure was increased in ANG, which was attenuated by 2 weeks of triple therapy (127, 191, and 143 mmHg for NORM, ANG, and ANG + TTx, respectively; p < 0.05). Total superoxide dismutase (SOD) activity in the small mesenteric arteries of ANG was lower than that of NORM. The protein expression of SOD1 was lower in ANG than in NORM, whereas SOD2 and SOD3 expression was not different between the groups. Reduced SOD activity and SOD1 expression in ANG was not restored in ANG + TTx. Both SOD activity and SOD isoform expression in the small renal vessels of ANG were not different from those of NORM. Interestingly, SOD activity in the small renal vessels was reduced by TTx. Between groups, there was no difference in catalase activity or expression in both the small mesenteric arteries and small renal vessels. In conclusion, SOD activity in the small mesenteric arteries decreased by angiotensin II administration, but not by hypertension, which is caused by decreased SOD1 expression.

Original languageEnglish (US)
Pages (from-to)363-370
Number of pages8
JournalToxicological Research
Volume34
Issue number4
DOIs
StatePublished - Oct 1 2018

Fingerprint

Mesenteric Arteries
Angiotensin II
Superoxide Dismutase
Rats
Down-Regulation
Hypertension
Antihypertensive Agents
Kidney
Antioxidants
Blood Pressure
Hydralazine
Hydrochlorothiazide
Reserpine
Blood pressure
Enzyme activity
Enzymes
Catalase
Blood Vessels
Protein Isoforms
Therapeutics

Keywords

  • Angiotensin II
  • Small vessels
  • Superoxide dismutase
  • Triple antihypertensive therapy

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Superoxide dismutase activity in small mesenteric arteries is downregulated by angiotensin II but not by hypertension. / Kang, Kyu Tae; Sullivan, Jennifer C; Pollock, Jennifer S.

In: Toxicological Research, Vol. 34, No. 4, 01.10.2018, p. 363-370.

Research output: Contribution to journalArticle

@article{864e995f95294faf85eae90ee2d28109,
title = "Superoxide dismutase activity in small mesenteric arteries is downregulated by angiotensin II but not by hypertension",
abstract = "Many studies reported reduced antioxidant capacity in the vasculature under hypertensive conditions. However, little is known about the effects of antihypertensive treatments on the regulation of vascular antioxidant enzymes. Thus, we hypothesized that antihypertensive treatments prevent the reduction of antioxidant enzyme activity and expression in the small vessels of angiotensin II-induced hypertensive rats (ANG). We observed the small mesenteric arteries and small renal vessels of normotensive rats (NORM), ANG, and ANG treated with a triple antihypertensive therapy of reserpine, hydrochlorothiazide, and hydralazine (ANG + TTx). Systolic blood pressure was increased in ANG, which was attenuated by 2 weeks of triple therapy (127, 191, and 143 mmHg for NORM, ANG, and ANG + TTx, respectively; p < 0.05). Total superoxide dismutase (SOD) activity in the small mesenteric arteries of ANG was lower than that of NORM. The protein expression of SOD1 was lower in ANG than in NORM, whereas SOD2 and SOD3 expression was not different between the groups. Reduced SOD activity and SOD1 expression in ANG was not restored in ANG + TTx. Both SOD activity and SOD isoform expression in the small renal vessels of ANG were not different from those of NORM. Interestingly, SOD activity in the small renal vessels was reduced by TTx. Between groups, there was no difference in catalase activity or expression in both the small mesenteric arteries and small renal vessels. In conclusion, SOD activity in the small mesenteric arteries decreased by angiotensin II administration, but not by hypertension, which is caused by decreased SOD1 expression.",
keywords = "Angiotensin II, Small vessels, Superoxide dismutase, Triple antihypertensive therapy",
author = "Kang, {Kyu Tae} and Sullivan, {Jennifer C} and Pollock, {Jennifer S.}",
year = "2018",
month = "10",
day = "1",
doi = "10.5487/TR.2018.34.4.363",
language = "English (US)",
volume = "34",
pages = "363--370",
journal = "Toxicological Research",
issn = "1976-8257",
publisher = "Koreal Association of Medical Journal Editors",
number = "4",

}

TY - JOUR

T1 - Superoxide dismutase activity in small mesenteric arteries is downregulated by angiotensin II but not by hypertension

AU - Kang, Kyu Tae

AU - Sullivan, Jennifer C

AU - Pollock, Jennifer S.

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Many studies reported reduced antioxidant capacity in the vasculature under hypertensive conditions. However, little is known about the effects of antihypertensive treatments on the regulation of vascular antioxidant enzymes. Thus, we hypothesized that antihypertensive treatments prevent the reduction of antioxidant enzyme activity and expression in the small vessels of angiotensin II-induced hypertensive rats (ANG). We observed the small mesenteric arteries and small renal vessels of normotensive rats (NORM), ANG, and ANG treated with a triple antihypertensive therapy of reserpine, hydrochlorothiazide, and hydralazine (ANG + TTx). Systolic blood pressure was increased in ANG, which was attenuated by 2 weeks of triple therapy (127, 191, and 143 mmHg for NORM, ANG, and ANG + TTx, respectively; p < 0.05). Total superoxide dismutase (SOD) activity in the small mesenteric arteries of ANG was lower than that of NORM. The protein expression of SOD1 was lower in ANG than in NORM, whereas SOD2 and SOD3 expression was not different between the groups. Reduced SOD activity and SOD1 expression in ANG was not restored in ANG + TTx. Both SOD activity and SOD isoform expression in the small renal vessels of ANG were not different from those of NORM. Interestingly, SOD activity in the small renal vessels was reduced by TTx. Between groups, there was no difference in catalase activity or expression in both the small mesenteric arteries and small renal vessels. In conclusion, SOD activity in the small mesenteric arteries decreased by angiotensin II administration, but not by hypertension, which is caused by decreased SOD1 expression.

AB - Many studies reported reduced antioxidant capacity in the vasculature under hypertensive conditions. However, little is known about the effects of antihypertensive treatments on the regulation of vascular antioxidant enzymes. Thus, we hypothesized that antihypertensive treatments prevent the reduction of antioxidant enzyme activity and expression in the small vessels of angiotensin II-induced hypertensive rats (ANG). We observed the small mesenteric arteries and small renal vessels of normotensive rats (NORM), ANG, and ANG treated with a triple antihypertensive therapy of reserpine, hydrochlorothiazide, and hydralazine (ANG + TTx). Systolic blood pressure was increased in ANG, which was attenuated by 2 weeks of triple therapy (127, 191, and 143 mmHg for NORM, ANG, and ANG + TTx, respectively; p < 0.05). Total superoxide dismutase (SOD) activity in the small mesenteric arteries of ANG was lower than that of NORM. The protein expression of SOD1 was lower in ANG than in NORM, whereas SOD2 and SOD3 expression was not different between the groups. Reduced SOD activity and SOD1 expression in ANG was not restored in ANG + TTx. Both SOD activity and SOD isoform expression in the small renal vessels of ANG were not different from those of NORM. Interestingly, SOD activity in the small renal vessels was reduced by TTx. Between groups, there was no difference in catalase activity or expression in both the small mesenteric arteries and small renal vessels. In conclusion, SOD activity in the small mesenteric arteries decreased by angiotensin II administration, but not by hypertension, which is caused by decreased SOD1 expression.

KW - Angiotensin II

KW - Small vessels

KW - Superoxide dismutase

KW - Triple antihypertensive therapy

UR - http://www.scopus.com/inward/record.url?scp=85057168386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057168386&partnerID=8YFLogxK

U2 - 10.5487/TR.2018.34.4.363

DO - 10.5487/TR.2018.34.4.363

M3 - Article

AN - SCOPUS:85057168386

VL - 34

SP - 363

EP - 370

JO - Toxicological Research

JF - Toxicological Research

SN - 1976-8257

IS - 4

ER -